This case report highlights the risk of severe rhabdomyolysis when nicotinic acid is added to lovastatin therapy.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to possible nicotinic acid-statin interaction; single case leaves open need for systematic safety data.
Reaven et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: